Boehringer Misused Forfeited Retirement Funds, Suit Says

Pharmaceutical giant Boehringer Ingelheim cost workers millions of dollars by using forfeited retirement plan funds to cover company contributions rather than administrative fees charged to participants, according to a proposed class...

Already a subscriber? Click here to view full article